1178753

Biogen U.S. Corporation — FEI 3010164829

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 26, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Durham, NC (United States)